Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mentor Breast Implant Sales Up 23% Despite Silicone Approval Delay

This article was originally published in The Gray Sheet

Executive Summary

Mentor's silicone gel breast implant approval will be delayed at least until 2005 due to the political controversy surrounding the device, according to Peter Nicholson, VP-strategic planning and investor relations

You may also be interested in...



Breast Implant Rupture Causes, Effects Assessed In FDA Guide, Data Review

Medical interventions such as biopsy and mammography are among possible causes of implant rupture cited in an FDA Breast Implant Customer Handbook, released June 9

Breast Implant Rupture Causes, Effects Assessed In FDA Guide, Data Review

Medical interventions such as biopsy and mammography are among possible causes of implant rupture cited in an FDA Breast Implant Customer Handbook, released June 9

Litigation In Brief

J&J/Medtronic stent litigation: Supreme Court declines to review ruling awarding Johnson & Johnson/Cordis $271 mil. for infringement of stent patents, including those related to its Palmaz-Schatz('762), denying a writ of certiorari in the case. The U.S. Court of Appeals for the Federal Circuit had denied a rehearing in September 2003 after siding with J&J last August and remanded the case back to its original Wilmington, Del. district court (1"The Gray Sheet" Oct. 6, 2003, In Brief). Medtronic notes that the stents at issue are obsolete...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020286

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel